CONMED Corporation (CNMD) support and resistance · P/E 19, rev $1.37B
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
This page maps CONMED Corporation (CNMD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CNMD revenue for 2025-12-31 was $1.37B. Net income was $47.1M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CNMD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CNMD quote page for the session range and the stock page for the full model.
Not investment advice.